Generative AI in Pharma: How Do You Prepare the Wider Organization to use Generative AI to get a Real Value-Add?
The Pharma industry is also being transformed by Generative AI. Do not miss how you could help your company get a real value-add.
Phil Winkworth
Alice Nyborg
From adherence to outcomes: The Patient Support Programme of the future
Discover how the new generation of PSPs are showing the way by creating an integrated environment where human engagement, technology and data co-exist in symbiosis.
Magnus Franzén-Rossi
CISO Radar: 2024 – A Year of Adaptation, Collaboration, and Transformation in Cybersecurity
The CISO radar explores 2024’s key cybersecurity challenges.
Gerome Billois
Coraline Joly
How to strengthen and harmonize the operational risk control framework management in the CIBs?
The recent operational risk management failings witnessed at Credit Suisse testify once more of the attention Corporate and Investment Banks (CIBs) need to give towards efficiently manage their risks and towards planning operational controls.
Flavia Dayde
Blurring the Boundaries: Why the rise in remote working calls for stronger commitments to Zero Trust Security
A deep dive into the impact of rising remote working calls on Zero Trust Security.
Nathalie Balabhadra
Network Sourcing: How Can Costs Be Reduced By 10-40%?
Find out how changing technologies and a changing marketplace can create significant opportunities to reduce costs and optimise performance
John Gorrell
Radar 2024 of startups in the second-hand luxury market
Wavestone presents the first edition of the radar focused on the startups with an expertise in the second-hand industry to accompany you with our implementation expertise and their innovative technologies in adoption of second-hand business model.
Julien Miniconi
Priyam Sabharwal
Hanaëlle Barnet
Competing through ‘Customer’ Value: 5 concrete steps towards an exciting new era for life science
This white paper closely examines the dynamics of the situation by investigating why change is needed and outlining practical ways life science companies can effectively evolve in current and future market environments.
Mike Bellis